Wagar et al., 2021 - Google Patents
Modeling human adaptive immune responses with tonsil organoidsWagar et al., 2021
View PDF- Document ID
- 5612824396988405620
- Author
- Wagar L
- Salahudeen A
- Constantz C
- Wendel B
- Lyons M
- Mallajosyula V
- Jatt L
- Adamska J
- Blum L
- Gupta N
- Jackson K
- Yang F
- Röltgen K
- Roskin K
- Blaine K
- Meister K
- Ahmad I
- Cortese M
- Dora E
- Tucker S
- Sperling A
- Jain A
- Davies D
- Felgner P
- Hammer G
- Kim P
- Robinson W
- Boyd S
- Kuo C
- Davis M
- Publication year
- Publication venue
- Nature medicine
External Links
Snippet
Most of what we know about adaptive immunity has come from inbred mouse studies, using methods that are often difficult or impossible to confirm in humans. In addition, vaccine responses in mice are often poorly predictive of responses to those same vaccines in …
- 210000002741 Palatine Tonsil 0 title abstract description 66
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wagar et al. | Modeling human adaptive immune responses with tonsil organoids | |
Heit et al. | Vaccination establishes clonal relatives of germinal center T cells in the blood of humans | |
Waickman et al. | Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling | |
Arumugakani et al. | Early emergence of CD19-negative human antibody-secreting cells at the plasmablast to plasma cell transition | |
Douam et al. | Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses | |
Matsumoto et al. | Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity | |
Cao et al. | Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization | |
Mount et al. | Multiple dendritic cell populations activate CD4+ T cells after viral stimulation | |
Lu et al. | Engineered murine HSCs reconstitute multi-lineage hematopoiesis and adaptive immunity | |
Budeus et al. | Human cord blood B cells differ from the adult counterpart by conserved Ig repertoires and accelerated response dynamics | |
Morrocchi et al. | Modeling human immune responses to vaccination in vitro | |
Sun et al. | The kinase PDK1 is critical for promoting T follicular helper cell differentiation | |
Eaton et al. | Bone marrow precursor cells from aged mice generate CD4 T cells that function well in primary and memory responses | |
CN114230658A (en) | Novel coronavirus-specific T cell receptor and uses thereof | |
Deng et al. | Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+ IFNγ-Thpp cells | |
Choi et al. | Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection | |
Sharma et al. | The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity | |
Barroso et al. | Molecular dissection of the antibody response: opportunities and needs for application in cattle | |
Feng et al. | Pathogen-associated T follicular helper cell plasticity is critical in anti-viral immunity | |
Wang et al. | A comprehensive analysis of the T and B lymphocytes repertoire shaped by HIV vaccines | |
Chai et al. | A high-throughput single cell-based antibody discovery approach against the full-length SARS-CoV-2 spike protein suggests a lack of neutralizing antibodies targeting the highly conserved S2 domain | |
US20230235284A1 (en) | Systems and methods to model adaptive immune responses | |
Paciello et al. | B cell maturation restored ancestral germlines to control Omicron BA. 2.86 | |
US20250066729A1 (en) | Systems and Methods Incorporating Modified T-Cells | |
Fujitani et al. | Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study |